Lantheus (NASDAQ:LNTH – Free Report) had its price target increased by Truist Financial from $82.00 to $96.00 in a report issued on Friday, Benzinga reports. The firm currently has a buy rating on the medical equipment provider’s stock. Several other brokerages have also commented on LNTH. JMP Securities reissued a market outperform rating and set […]